BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 27093577)

  • 1. Chemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer Cells.
    van Gisbergen MW; Cebula M; Zhang J; Ottosson-Wadlund A; Dubois L; Lambin P; Tew KD; Townsend DM; Haenen GR; Drittij-Reijnders MJ; Saneyoshi H; Araki M; Shishido Y; Ito Y; Arnér ES; Abe H; Morgenstern R; Johansson K
    Mol Pharm; 2016 Jun; 13(6):2010-25. PubMed ID: 27093577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance.
    Johansson K; Ito M; Schophuizen CM; Mathew Thengumtharayil S; Heuser VD; Zhang J; Shimoji M; Vahter M; Ang WH; Dyson PJ; Shibata A; Shuto S; Ito Y; Abe H; Morgenstern R
    Mol Pharm; 2011 Oct; 8(5):1698-708. PubMed ID: 21851097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of glutathione-related genes, enzyme activities and transport proteins in human cervical cancer cells treated with doxorubicin.
    Drozd E; Krzysztoń-Russjan J; Marczewska J; Drozd J; Bubko I; Bielak M; Lubelska K; Wiktorska K; Chilmonczyk Z; Anuszewska E; Gruber-Bzura B
    Biomed Pharmacother; 2016 Oct; 83():397-406. PubMed ID: 27424321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Majumder S; Dutta P; Mookerjee A; Choudhuri SK
    Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsomal glutathione transferase 1 in anticancer drug resistance.
    Johansson K; Ahlen K; Rinaldi R; Sahlander K; Siritantikorn A; Morgenstern R
    Carcinogenesis; 2007 Feb; 28(2):465-70. PubMed ID: 16920737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulphonamide-based bombesin prodrug analogues for glutathione transferase, useful in targeted cancer chemotherapy.
    Axarli I; Labrou NE; Petrou C; Rassias N; Cordopatis P; Clonis YD
    Eur J Med Chem; 2009 May; 44(5):2009-16. PubMed ID: 19019494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human glutathione transferases catalyzing the bioactivation of anticancer thiopurine prodrugs.
    Eklund BI; Gunnarsdottir S; Elfarra AA; Mannervik B
    Biochem Pharmacol; 2007 Jun; 73(11):1829-41. PubMed ID: 17433263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents.
    Townsend AJ; Tu CP; Cowan KH
    Mol Pharmacol; 1992 Feb; 41(2):230-6. PubMed ID: 1538704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of resistance against doxorubicin by a newly developed compound, oxalyl bis(N-phenyl)hydroxamic acid in vitro.
    Choudhuri SK; Chatterjee A
    Anticancer Drugs; 1998 Oct; 9(9):825-32. PubMed ID: 9840730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
    de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
    Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cisplatin-based platinum(IV) prodrug containing a glutathione s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer.
    Chen H; Wang X; Gou S
    J Inorg Biochem; 2019 Apr; 193():133-142. PubMed ID: 30731264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells. Inhibition of glutathione S-transferase p1-1 by glutathione conjugates from anthracyclines.
    Gaudiano G; Koch TH; Lo Bello M; Nuccetelli M; Ravagnan G; Serafino A; Sinibaldi-Vallebona P
    Biochem Pharmacol; 2000 Dec; 60(12):1915-23. PubMed ID: 11108808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β-elemene.
    Xu HB; Li L; Fu J; Mao XP; Xu LZ
    Pharmacology; 2012; 89(5-6):303-12. PubMed ID: 22573000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione transferase activity with a novel substrate mimics the activation of the prodrug azathioprine.
    Kurtovic S; Grehn L; Karlsson A; Hellman U; Mannervik B
    Anal Biochem; 2008 Apr; 375(2):339-44. PubMed ID: 18211812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.
    Zaja R; Caminada D; Loncar J; Fent K; Smital T
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):207-18. PubMed ID: 18076962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of in vitro pro-drug activation and futile cycling by glutathione S-transferases: thiol ester hydrolysis and inhibitor maturation.
    Ibarra C; Grillo MP; Lo Bello M; Nucettelli M; Bammler TK; Atkins WM
    Arch Biochem Biophys; 2003 Jun; 414(2):303-11. PubMed ID: 12781783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH; Lewis AD; Ehsan MN; Sikic BI
    Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-variation of glutathione transferase expression and cytostatic drug resistance in HeLa cells: establishment of class Mu glutathione transferase M3-3 as the dominating isoenzyme.
    Hao XY; Widersten M; Ridderström M; Hellman U; Mannervik B
    Biochem J; 1994 Jan; 297 ( Pt 1)(Pt 1):59-67. PubMed ID: 8280111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the anti-cervical cancer effect of a prodrug :CBZ-AAN-DOX with hypoxic cell culture and tumor-bearing zebrafish models.
    Chen HC; Rui W; You SY; Liu XW; Huang J; Chen HY
    Exp Cell Res; 2020 Jun; 391(1):111980. PubMed ID: 32229193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.